Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 29;24(7):185.
doi: 10.31083/j.rcm2407185. eCollection 2023 Jul.

Management of Cardiovascular Diseases in Chronic Hemodialysis Patients

Zhen Zhang  1   2   3   4 , Yaqiong Wang  1   2   3   4
Affiliations
Review

Management of Cardiovascular Diseases in Chronic Hemodialysis Patients

Zhen Zhang et al. Rev Cardiovasc Med. .

Abstract

Hemodialysis (HD) is the main treatment modality for patients with end-stage kidney disease. Cardiovascular diseases (CVD) are highly prevalent in HD patients and are the leading cause of death in this population, with the mortality from CVD approximately 20 times higher than that of the general population. Traditional and non-traditional cardiovascular risk factors accelerate progression of CVD and exacerbate the prognosis in HD patients. This review provides a brief overview of the characteristics of CVD in HD patients, and a description of advances in its management.

Keywords: cardiovascular disease; end-stage kidney disease; hemodialysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Potential impact of volume overload, increased ultrafiltration rate and adverse cardiac outcome.
See this image and copyright information in PMC

References

    1. Fox CS, Matsushita K, Woodward M, Bilo HJG, Chalmers J, Heerspink HJL, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet . 2012;380:1662–1673. - PMC - PubMed
    1. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet . 2012;380:1649–1661. - PMC - PubMed
    1. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. The American Journal of Medicine . 2003;115:291–297. - PubMed
    1. Foley RN, Parfrey PS, Harnett JD. Left Ventricular Hypertrophy in Dialysis Patients. Seminars in Dialysis . 1992;5:34–41.
    1. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrology, Dialysis, Transplantation . 1996;11:1277–1285. - PubMed

LinkOut - more resources